脑血管疾病的无处不在调节由无处不在胺修饰酶
Jingyong Huang1, Zhenhu Zhu2, Dirk Schlüter3
1Department of Vascular Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Clinical and translational medicine
|May 23, 2024
概括
乌比基修饰酶 (UME) 在调节脑血管疾病 (CVD) 中至关重要. 针对UMEs和相关疗法,为治疗中风和动脉样硬化等疾病提供了有希望的新途径.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 神经科学是一个神经科学.
背景情况:
- 脑血管疾病 (CVD) 构成了全球健康的重大负担.
- 了解心血管疾病的分子基础对于开发有效的治疗方法至关重要.
- 乌比基胺修饰酶 (UMEs) 已成为心血管疾病病理学的关键调节剂.
研究的目的:
- 突出UMEs在各种心血管疾病的发病过程中的关键作用.
- 探索UMEs作为脑血管疾病的潜在治疗点.
- 讨论UME向策略在心血管疾病治疗中的未来影响.
主要方法:
- 对UME及其参与心血管疾病的现有文献的审查.
- 分析大脑血管病理中无处不在的调节功能.
- 基于UME调制的新型治疗方式的探索.
主要成果:
- UMEs在调节缺血性中风,出血性中风,莫亚莫亚病和动脉样硬化等病理过程中发挥着重要作用.
- UMEs涉及各种细胞功能,这些功能对脑血管健康至关重要.
- 无处不在的机器是CVD分子格局的核心参与者.
结论:
- UMEs代表了有希望的可用药物的目标,用于开发针对心血管疾病的新疗法.
- 先进的技术,如蛋白质溶解向奇美拉和二维基酸向奇美拉,有可能彻底改变心血管疾病的治疗.
- 对UME功能的进一步研究可能会为脑血管疾病提供新的预防和治疗策略.
更多相关视频
07:05Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay
Published on: September 27, 2024
444
09:45Method for Measuring the Activity of Deubiquitinating Enzymes in Cell Lines and Tissue Samples
Published on: May 10, 2015
9.7K
相关概念视频
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
The Proteasome
830
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
830
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Regulation of Expression at Multiple Steps
892
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
892
The Blood-brain Barrier
47.2K
Overview
47.2K
